Introducing Celora™ Vita: a biorestorative injectable that addresses skin ageing at its source
Much of what we understand as skin ageing is not simply the passage of time. It is the progressive depletion of the raw materials the dermis needs to maintain itself, the amino acid substrates that fibroblasts rely on to synthesise collagen, elastin and the extracellular matrix. When those substrates run low, the skin’s ability to repair and renew becomes limited, and no amount of volumisation addresses that underlying deficit. Celora™ Vita has been developed to replenish what is missing at a biological level. With this launch, DermaFocus marks its next strategic step, evolving from a trusted distributor into a brand owner and leader in regenerative aesthetics.
Celora™ Vita: a biorestorative injectable approachCelora™ Vita is an injectable formulation medical device intended for intradermal administration to support full facial skin biorestoration and overall skin quality improvement…
